medical device investing Spectral Expands its Renal Replacement Therapy Development Program to Include the Home Dialysis Market
Spectral Announces Publication of the post hoc analysis of EUPHRATES trial in Intensive Care Medicine
Alvopetro Announces Q3 2026 Dividend of US$0.12 Per Share and Supplementary Information on December 31, 2025 Prospective Resources
Skyharbour Partner Company Purecore Commences Data Compilation and Target Generation at The Yurchison Uranium Property
